Fresh Recalls

Teva Pharmaceuticals USA recalls

3 recent recalls on record for Teva Pharmaceuticals USA in connected official government data as of October 22, 2026 at 6:00 PM UTC.

Models with recalls

Claravis (isotretinoin capsule (1)Octreotide Acetate for Injectable Suspension (1)traZODone Hydrochloride Tablets (1)

All Teva Pharmaceuticals USA recalls

FDA Class II · Drug · September 9, 2026

traZODone Hydrochloride Tablets recall — Teva Pharmaceuticals USA, Inc

Presence of Foreign Tablets/Capsules

Official ID D-0834-2026 · Official record ↗

FDA Class II · Drug · May 13, 2026

Octreotide Acetate for Injectable Suspension recall — Teva Pharmaceuticals USA, Inc

Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the contract manufacturer.

Official ID D-0519-2026 · Official record ↗

FDA Class II · Drug · April 29, 2026

Claravis (isotretinoin capsule recall — Teva Pharmaceuticals USA, Inc

Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin

Official ID D-0521-2026 · Official record ↗

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from official public-domain government data. Last checked October 22, 2026 at 6:00 PM UTC.